Ally Bridge Group (NY) LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ally Bridge Group (NY) LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$4,360,000
-43.3%
60,000
-7.7%
3.23%
+20.3%
Q4 2021$7,686,000
-11.9%
65,0000.0%2.69%
+4.8%
Q3 2021$8,720,000
-42.2%
65,000
-30.2%
2.56%
-31.6%
Q2 2021$15,078,000
-16.5%
93,127
-58.6%
3.75%
+8.2%
Q1 2021$18,057,000
+47.5%
225,0000.0%3.46%
+65.0%
Q4 2020$12,240,000225,0002.10%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders